Identification of CDK4 as a target of c-MYC

Cited by papers we hold 10

• MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies · 2021
  Corrected
• Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling · 2021
  No notice
• Transcription Factors in Cancer Development and Therapy · 2020
  No notice
• Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation · 2019
  No notice
• MYC Oncogene Contributions to Release of Cell Cycle Brakes · 2019
  No notice
• Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis · 2019
  No notice
• Ubiquitination by HUWE1 in tumorigenesis and beyond · 2018
  No notice
• Oncogenic regulation of tumor metabolic reprogramming · 2016
  No notice
• Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells · 2014
  No notice
• Global Regulation of Nucleotide Biosynthetic Genes by c-Myc · 2008
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.